Get ready for IHI call 13 – a word from our director
One call for is closing, and another one will open soon – with more opportunities for partnerships between industry, researchers, healthcare and civil society. Many of you will have spent the last weeks polishing proposals for IHI call 12 ahead of last week’s deadline, and we have now published the draft topics for our call 13, which will open in summer.
At IHI we publish our draft topics when they are sent out for consultation with our governance groups – we think the transparency is important, but most importantly it gives everyone the opportunity to start reaching out to potential collaborators. The call 13 topics are a case in point: the topics are ambitious and multidisciplinary, and successful proposals will need to build new connections across different expertise and organisations.
This month we published an article summarising our projects on NAMs – new approaches and methods to reduce, refine and replace animals in the development of medicines and medical devices. This is a great example of how public-private partnerships drive real progress – taking excellent research all the way through the innovation journey to regulatory approval and deployment. The replacement of pyrogen testing of vaccines with cell-based assays is saving tens of thousands of animals. In call 13 we have the next topic in this series – a call for innovative approaches to waive the need for a second species in medicines toxicology.
Enjoy the read!
Niklas Blomberg, IHI Executive Director
At IHI we publish our draft topics when they are sent out for consultation with our governance groups – we think the transparency is important, but most importantly it gives everyone the opportunity to start reaching out to potential collaborators. The call 13 topics are a case in point: the topics are ambitious and multidisciplinary, and successful proposals will need to build new connections across different expertise and organisations.
This month we published an article summarising our projects on NAMs – new approaches and methods to reduce, refine and replace animals in the development of medicines and medical devices. This is a great example of how public-private partnerships drive real progress – taking excellent research all the way through the innovation journey to regulatory approval and deployment. The replacement of pyrogen testing of vaccines with cell-based assays is saving tens of thousands of animals. In call 13 we have the next topic in this series – a call for innovative approaches to waive the need for a second species in medicines toxicology.
Enjoy the read!
Niklas Blomberg, IHI Executive Director
Read the draft topic texts for IHI call 13
The call is scheduled for launch in the summer and includes topics on a healthcare incubator network, the use of AI in toxicology studies, and age-related diseases.
Read more
How IHI and IMI are replacing, reducing and refining the use of animals in health research
On World Lab Animals Day, we celebrated projects that are replacing, reducing and refining the use of animals in research.
Engaging with policymakers to promote liver screening
Ahead of World Liver Day, the GRIPonMASH project talked to IHI about why it’s important to engage with policymakers to make liver screening a more routine part of healthcare.
Can data capture on heart patients’ healthcare and quality of life be improved?
The iCARE4CVD project investigated how well the tools researchers use to evaluate how heart patients feel about their healthcare are working and how they are perceived by patients.
A step change in the diagnosis and care of a common heart problem
AF-B-STEP aims to transform the way we diagnose and treat atrial fibrillation, so that we can improve care and help patients avoid heart failure, stroke, and other complications.
Together for Health, Stand with Science
The theme of this year’s World Health Day, ‘together for health, stand with science’, resonates with IHI’s goal to support ambitious collaborative projects driving bold transformations in health.
Launching a career in interventional radiology with the SHERPA project
Janneke Burger describes her work on imaging brain aneurysms and explains the advantages of working in a public-private partnership during her PhD at UMC Utrecht.
Meet IHI at the MedTech Forum in Stockholm on 11-13 May
IHI will have a stand at the MedTech Forum exhibition and feature in sessions on the use of real world data to advance healthcare; early feasibility studies; and AI in healthcare.
Read more
Join our masterclass on the exploitation of project results
Join our interactive online masterclass on 3 June and discover our Field Manual on scaling innovations emerging from public-private partnerships.
Catch up on our IHI coordinators’ training day
Although it was designed for project coordinators, the presentations on issues such as reporting (both scientific and financial), audits, and communication are likely to be useful for all IHI project participants.